CHOLINESTERASE INHIBITORS AND MEMANTINE FOR THE TREATMENT OF ALZHEIMER AND NON-ALZHEIMER DEMENTIAS

被引：21

作者：

Balazs, Nora ^{[1
]}

Bereczki, Daniel ^{[1
,2
]}

Kovacs, Tibor ^{[1
,2
]}

机构：

[1] Semmelweis Univ, Dept Neurol, Balassa U 6, H-1083 Budapest, Hungary

[2] MTA SE Neuroepidemiol Res Grp ELKH, Budapest, Hungary

来源：

IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE | 2021年 / 74卷 / 11-12期

关键词：

dementia; therapy; treatment; cholinesterase inhibitors; memantine; ACETYLCHOLINESTERASE INHIBITORS; ANTIDEMENTIA DRUGS; DISEASE; ASSOCIATION; DIAGNOSIS; MODERATE; RIVASTIGMINE; MANAGEMENT; ATROPHY;

D O I：

10.18071/isz.74.0379

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

In aging societies, the morbidity and mortality of dementia is increasing at a significant rate, thereby imposing burden on healthcare, economy and the society as well. Patients' and caregivers' quality of life and life expectancy are greatly determined by the early diagnosis and the initiation of available symptomatic treatments. Cholinesterase inhibitors and memantine have been the cornerstones of Alzheimer's therapy for approximately two decades and over the years, more and more experience has been gained on their use in non-Alzheimer's dementias too. The aim of our work was to provide a comprehensive summary about the use of cholinesterase inhibitors and memantine for the treatment of Alzheimer's and non-Alzheimers's dementias.

引用

页码：379 / 387

页数：9

共 50 条

[41] Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias
Allan, LM
Ballard, CG
Burn, DJ
Kenny, RA
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (10) : 1681 - 1687
[42] Cognitive Improvement After Ventriculoperitoneal Shunt Placement in Alzheimer Disease and non-Alzheimer Dementias
Donahue, John
Johanson, Conrad
Klinge, Petra
Stopa, Edward
Salloway, Stephen
Ott, Brian
Mernoff, Stephen
Stoukides, John
de la Monte, Suzanne
Miller, Miles
Silverberg, Gerald
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2010, 69 (05): : 551 - 551
[43] Treatment With Cholinesterase Inhibitors and Memantine of Patients in the Alzheimer's Disease Neuroimaging Initiative
Schneider, Lon S.
Insel, Philip S.
Weiner, Michael W.
ARCHIVES OF NEUROLOGY, 2011, 68 (01) : 58 - 66
[44] Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease
Rountree, Susan D.
Chan, Wenyaw
Pavlik, Valory N.
Darby, Eveleen J.
Siddiqui, Samina
Doody, Rachelle S.
ALZHEIMERS RESEARCH & THERAPY, 2009, 1 (02):
[45] Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease
Susan D Rountree
Wenyaw Chan
Valory N Pavlik
Eveleen J Darby
Samina Siddiqui
Rachelle S Doody
Alzheimers Res Ther, 1
[46] Molecular biology of APO E alleles in Alzheimer's and non-Alzheimer's dementias
Morris, CM
Massey, HM
Benjamin, R
Leake, A
Broadbent, C
Griffiths, M
Lamb, H
Brown, A
Ince, PG
Tyrer, S
Thompson, P
McKeith, IG
Edwardson, JA
Perry, RH
Perry, EK
JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1996, (47): : 205 - 218
[47] The Importance of Dopamine Deficiency Evaluation in Non-Alzheimer Disease Dementias
Alkharisi, Bader
Dostzada, Khaled
Kaur, Harleen
Kumar, Manoj
Wei, Jeanne Y.
Azhar, Gohar
AMERICAN JOURNAL OF CASE REPORTS, 2023, 24
[48] Pathologic issues and new methodologies in the evaluation of non-Alzheimer dementias
Vinters, HV
Klement, IA
Sung, SH
Farag, ES
CLINICAL NEUROSCIENCE RESEARCH, 2004, 3 (06) : 413 - 426
[49] TEST YOUR MEMORY (TYM) TESTING IN NON-ALZHEIMER DEMENTIAS
Brown, J.
Reddy, S.
Cunningham, K.
Dong, H.
Ibram, F.
Clatworthy, P.
Wiggins, J.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83
[50] Genetic architecture of common non-Alzheimer's disease dementias
Guerreiro, Rita
Gibbons, Elizabeth
Tabuas-Pereira, Miguel
Kun-Rodrigues, Celia
Santo, Gustavo C.
Bras, Jose
NEUROBIOLOGY OF DISEASE, 2020, 142

← 1 2 3 4 5 →